Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor

Wiener Klinische Wochenschrift, Supplement

Volumn 116, Issue 2, 2004, Pages 5-7

  Baklan, Zvonko ^a   Gorišek, Jelka Reberšek ^a   Poljak, Mario ^b   Pišec, Andrej ^c  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c Primary Health Care Centre   (Slovenia)

Author keywords

Hepatitis; HIV; Injecting drug users; Methadone

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG DEPENDENCE; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS G; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MALE; METHADONE TREATMENT; PREVALENCE; SLOVENIA; VACCINATION; VIRUS INFECTION;

ADULT; AGE FACTORS; CROSS-SECTIONAL STUDIES; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS B; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; MALE; METHADONE; NARCOTICS; SEX FACTORS; SLOVENIA; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 3242743771     PISSN: 03005178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Garfein RS, Vlahov D, Doherty MC, Nelson KE (1996) Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 86: 655-661
2. Robaczewska M, Cova L, Podhajska AJ, Falkiewicz B (1999) Hepatitis G Virus: molecular organization, methods of detection, prevalence, and disease association. Int J Infect Dis 3: 220-233
3. Müller C (1999) The hepatitis alphabet - Hepatitis A-G and TTV. Wien Klin Wochenschr 12: 461-468
4. Hogan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Aleksander ER (2001) Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 91: 42-46
5. Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I (1996) Frontloading: a risk factor for HIV an hepatitis C virus infection among injecting drug users in Berlin. AIDS 10: 311-317
6. Nolimal D (2000) Razşirjenost rabe nedovoljenih drog v Sloveniji. Odsev 2: 34
7. Dekleva B (1998) Droge med srednješolsko mladino v Ljubljani. Mestna občina, Mestna uprava, Urad za preprčevanje zasvojenosti, Inštitut za kriminologijo pri Pravni fakulteti v Ljubljani. Ljubljana 1998 (str. 54)
8. Flaker V, Grehenc V, Rode N, et al (1999) Podobe uživanja heroina v Sloveniji z vidika zmanjšvanja škode. Socialno delo 38: 341-393
9. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction (1998) Effective medical treatment of opiate addiction. JAMA 280: 1936-1943
10. Ward J, Hall W, Mattick RP (1999) Role of maintenance treatment in opioid dependence. Lancet 353: 221-226
11. Poljak M, Seme K (1998) Simple one-tube reverse transciption-polymerase chain reaction protocol containing anticontamination procedure for detection of GB virus C/hepatitis G virus RNA. J Virol Methods 71: 1-6
12. Levine OS, Vlahov D, Nelson KE (1994) Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev 16: 418-436
13. Stezinar SL (2000) Presejalno testiranje na označevalce virusnih okužb na Zavodu RS za transfuzijo krvi v obdobju 1995-1999. Med razgl 39 [Suppl 5]: 269
14. Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I (1997) History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol 26: 1359-1366
15. Lamagni TL, Davison KL, Hope VD, Luutu JW, Newham JA, Parry JV, et al (1999) Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996. Commun Dis Public Health 2: 174-177
16. Minniti F, Baldo V, Trivello R, Bricolo R, Di Furia L, Renzulli G, et al (1999) Response to HBV vaccine in relation to anti-HCV and anti-HBc positivity: a study in intravenous drug addicts. Vaccine 17: 3083-3085
17. Mathei C, Buntinx F, Van Damme P (2002) Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review. J Viral Hep 9: 157-173
18. Nubling CM, Bialleck H, Fursch AJ, Scharrer I, Schramm W, Seifried E, et al (1997) Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations. J Med Virol 53: 218-224
19. Hagan H, Des Jarlais DC (2000) HIV and HCV infection among injecting drug users. Mt Sinai J Med 67: 437-443